½ÃÀ庸°í¼­
»óǰÄÚµå
1438032

¼¼°èÀÇ ÇǺΰú¿ë ¿µ»ó±â±â ½ÃÀå : Á¦Ç°º°, ¸ð´Þ¸®Æ¼º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ¼¼°èÀÇ ºÐ¼® ¿¹Ãø(-2030³â)

Dermatology Imaging Devices Market Forecasts to 2030 - Global Analysis By Product, Modality, Technology, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ÇǺΰú¿ë ¿µ»ó±â±â ¼¼°è ½ÃÀåÀº 2023³â 86¾ï 2, 000¸¸ ´Þ·¯¸¦ Â÷ÁöÇÏ¿´°í ¿¹Ãø ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 14.7%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç 2030³â¿¡´Â 125¾ï 4, 000¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù

ÇǺΰú ¿µ»ó Àåºñ´Â ÇǺΠÁúȯÀÇ Áø´Ü°ú ¸ð´ÏÅ͸µ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ÷´Ü ±â¼úÀ» ÀÌ¿ëÇÏ¿© ÇǺΠ±¸Á¶ÀÇ »ó¼¼ÇÑ À̹ÌÁö¸¦ Á¦°øÇÕ´Ï´Ù. ÇǺΰú ÀÇ»ç´Â µÎ´õÁö, º´º¯ ¹× ÇǺΠÀÌ»ó °Ë»ç¿¡ ÀÌ·¯ÇÑ ºñ ħ½ÀÀû µµ±¸¸¦ »ç¿ëÇÏ¿© ÇÇºÎ¾Ï ¹× ±âŸ ÇǺΠ°úÇÐÀû ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. °íÇØ»óµµ À̹ÌÁö´Â Áø´Ü Á¤È®µµ¸¦ ³ôÀÌ°í º¸´Ù È¿°úÀûÀÎ Ä¡·á °èȹÀ» ¼ö¸³Çϰí ÇǺΰú ºÎÀ§¿¡¼­ ȯÀÚÀÇ °á°ú °³¼±¿¡ ±â¿©ÇÕ´Ï´Ù.

¹Ì±¹¾ÏÇùȸÀÇ 2022³â Åë°è¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â 2022³â¿¡ 99, 780·ÊÀÇ ÇǺÎÈæ»öÁ¾ÀÌ »õ·Ó°Ô º¸°íµÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ±× Áß 57, 180¸íÀÌ ³²¼ºÀ̰í 42, 600¸íÀÌ ¿©¼ºÀÔ´Ï´Ù.

ÇǺΠÁúȯ Áõ°¡

Àα¸ÀÇ °í·ÉÈ­, ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­, °øÇØ µîÀÇ °á°ú, ÇǺΠÁúȯÀÇ ¹ß»ý·üÀÌ ³ô¾ÆÁü¿¡ µû¶ó, Á¤È®Çϰí È¿°úÀûÀÎ Áø´Ü ±â¼úÀÌ ÇǺΠ°úÇп¡ ÇÊ¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á°ü°èÀÚ°¡ ÇǺÎÁúȯÀÇ Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ Áø´ÜÀ» À§ÇØ ÃÖ÷´Ü ±â¼úÀ» ¿ä±¸ÇÏ´Â °¡¿îµ¥ ÇǺΰú¿ë ¿µ»ó±â±â ½ÃÀåÀº Å©°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÇǺΠƮ·¯ºíÀÇ ºóµµ »ó½Â¿¡ ´ëÀÀÇÏ´Â ½ÃÀå È®´ë¿¡ ±â¿©ÇÏ´Â ÀÌ Àåºñ´Â ºñħ½ÀÀûÀÎ °Ë»ç¸¦ Áö¿øÇϰí ÇǺΰú Áø·áÀÇ Àü¹ÝÀûÀÎ È¿À²¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

ÀÇ·á½Ã¼³ Á¢±Ù Á¦ÇÑ

°Ç°­ °ü¸® ÀÎÇÁ¶ó°¡ Á¦ÇÑµÈ Áö¿ª¿¡¼­ ȯÀÚ´Â Àû½Ã¿¡ ÇǺΰú Áø´Ü ¹× Ä¡·á¸¦ ¹Þ´Â µ¥ ¾î·Á¿òÀ» °Þ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ°¡ ÀûÀýÇÑ ÇǺΰú Ä¡·á¸¦ ¹Þ´Â °ÍÀÌ Áö¿¬µÉ ¼ö Àֱ⠶§¹®¿¡ °Ç°­ °ü¸®¿¡ ´ëÇÑ Á¢±Ù °ÝÂ÷µµ ÇǺΠÁúȯ ºÎ´ãÀ» ¾ÇÈ­½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ À庮Àº ÀÇ·á°¡ Àß µÇÁö ¾Ê´Â Áö¿ª¿¡ ºÒ±ÕÇü¿¡ ¿µÇâÀ» ¹ÌÄ¡°í, °Ç°­ °ü¸® °ÝÂ÷¸¦ ¾ÇÈ­½Ã۰í, ½ÃÀåÀÇ ÀáÀçÀû ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.

ÀÇ½Ä Áõ°¡¿Í ¹Ì¿ë ½Ã¼ú¿¡ ÁÖ¸ñ

ÇǺΠ°Ç°­°ú ¸Å·ÂÀÌ Á߽õʿ¡ µû¶ó ÇǺΰúÇп¡¼­ ±â¼úÀûÀ¸·Î °³¼±µÈ ¿µ»ó Áø´Ü Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ µµ±¸´Â ÇǺΠ¹®Á¦¸¦ È®ÀÎÇϰí ÃßÀûÇÏ´Â µ¥ ÇʼöÀûÀ̸ç Àü¹®°¡°¡ Á¤È®ÇÏ°í »ç¿ëÀÚ Á¤ÀÇ µÈ ¹Ì¿ë Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÃÖÀûÀÇ ºäƼ °á°ú¸¦ ¾ò´Â °Í¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö´Â °¡¿îµ¥, ÇǺΰú À̹Ì¡ Àåºñ ½ÃÀåÀº ÀÇ·á¿Í ¹Ì¿ë Áøº¸ÀÇ ±³Â÷·Î Áö¼ÓÀûÀÎ ¼ºÀåÀ» ±â´ëÇϰí ÀÖ½À´Ï´Ù.

°í±Þ È­»ó ó¸® ÀåÄ¡ÀÇ °íºñ¿ë

ÃÖ÷´Ü ±â¼úÀ» ÃëµæÇϰí À¯ÁöÇÏ´Â µ¥ µå´Â ºñ¿ëÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿Í ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Á¦ÇÑÇÕ´Ï´Ù. ÀÌ °æÁ¦Àû À庮ÀÌ º¸±ÞÀÇ ¹æÇذ¡ µÇ¾î, ¼Ò±Ô¸ð Ŭ¸®´ÐÀ̳ª ÇコÄÉ¾î ±â°üÀÌ ÃÖ÷´ÜÀÇ ÇǺΰú¿ë È­»ó ±â±â¿¡ ÅõÀÚÇÏ´Â ¹æÇذ¡ µÇ°í ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÚ¿øÀÇ ºÒ±ÕµîÇÑ ºÐ¹è´Â ÇǺΰú¿¡¼­ÀÇ Áøº¸µÈ Áø´Ü ´É·ÂÀÇ Àü¹ÝÀûÀÎ ¼ºÀå°ú Á¢±Ù¼ºÀ» ÀúÇØÇϰí, ȯÀÚ °ü¸® ¹× Áø´Ü Á¤È®µµ¸¦ ¼Õ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ À¯ÇàÀº ½ÃÀå¿¡ ´Ù¾çÇÑ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÇコÄÉ¾î ¼­ºñ½º Áߴܰú ÄÚºñµå °ü·Ã ÀÚ¿øÀÇ ¿ì¼±¼øÀ§È­·Î ÀÎÇØ óÀ½¿¡´Â ¼ö¿ä°¡ °¨¼ÒÇßÁö¸¸ ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀÌ È¸º¹µÇ¾ú½À´Ï´Ù. ÆÒµ¥¹ÍÀº °¡»ó ÁøÂû¿¡¼­ ÇǺΰú À̹ÌÁöÀÇ Á߿伺À» ºÎ°¢½ÃÄÑ Ã¤¿ëÀÇ ±ÞÁõÀ¸·Î À̾îÁý´Ï´Ù. ±×·¯³ª °ø±Þ¸ÁÀÇ È¥¶õ°ú °æÁ¦ÀÇ ºÒÈ®½Ç¼ºÀº ÇǺΰú ¿µ»ó Àåºñ ºÐ¾ß ½ÃÀå ¼ºÀå¿¡ °è¼Ó ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù.

¿¹Ãø±â°£ µ¿¾È ÇǺγ»½Ã°æ ºÐ¾ß°¡ ÃÖ´ëÈ­µÉ Àü¸Á

ÇǺΠ³»½Ã°æ ºÐ¾ß´Â À¯¸®ÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÇǺΠ³»½Ã°æÀº ÇǺΰú Àǻ簡 ÇǺÎÀÇ º´º¯À̳ª ÀÌ»óÀ» °Ë»çÇÏ´Â µ¥ »ç¿ëÇÏ´Â ÈÞ´ë¿ë ÀåºñÀÔ´Ï´Ù. ÀÌ È®Àå µµ±¸´Â ÇǺÎÀÇ ±ÙÁ¢ ÃÔ¿µº¸±â¸¦ Á¦°øÇÏ¿© Àü¹®°¡°¡ µÎ´õÁö, »ö¼Ò º´º¯ ¹× ±âŸ ÇǺΠ»óŸ¦º¸´Ù ¼±¸íÇÏ°Ô Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¢ÃËÇü, ºñÁ¢ÃËÇü µî ´Ù¾çÇÑ µðÀÚÀÎÀÇ ÇǺΰæÀº ÇǺΰú Áø´Ü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç ÇǺÎÀÇ °Ç°­ »óÅ¿¡ ´ëÇÑ º¸´Ù Á¤È®Çϰí ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÆÇ´ÜÀ» ÃËÁøÇÕ´Ï´Ù. ±× È޴뼺°ú »ç¿ëÀÇ ¿ëÀ̼º ¶§¹®¿¡ ÀÏ»óÀûÀÎ ÇǺΠ°Ë»ç¿¡ À־ ±ÍÁßÇÑ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÇÇºÎ¾Ï Áø´Ü ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) ¿¹»óµÈ´Ù.

ÇÇºÎ¾Ï Áø´Ü ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÇǺΰú¿ë ¿µ»ó±â±â´Â ºñħ½ÀÀûÀÌ°í °íÇØ»óµµ ÇǺΠ¿µ»óÀ» Á¦°øÇÔÀ¸·Î½á ÇÇºÎ¾Ï Áø´Ü¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ ÀåÄ¡´Â ÇǺΠº´º¯À» Á¤È®ÇÏ°Ô Æò°¡ÇÏ°í ¾ç¼º°ú ¾Ç¼º ¼ºÀåÀ» ±¸º°Çϸç ÃÖÀûÀÇ »ý°Ë À§Ä¡¸¦ °áÁ¤ÇÒ ¶§ ÇǺΰú Àǻ縦 Áö¿øÇÕ´Ï´Ù. ÀÌ ±â¼úÀº Á¶±â ¹ß°ßÀ» °­È­Çϰí Àû½Ã °³ÀÔ°ú ¿¹ÈÄ °³¼±À¸·Î À̾îÁý´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ Àåºñ´Â ºÒÇÊ¿äÇÑ »ý°ËÀ» ÃÖ¼ÒÈ­Çϰí ȯÀÚÀÇ ºÒÆíÇÔ°ú °Ç°­ °ü¸® ºñ¿ëÀ» Àý°¨ÇÕ´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇǺΠ°Ç°­¿¡ ´ëÇÑ ÀǽÄÀÌ Áõ°¡Çϰí ÇǺΰú ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ÁÖ¿ä ±â¾÷ÀÎ Minolta¿Í Nidek CorporationÀº R&D¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç À̹ÌÁö ¼Ö·ç¼ÇÀÇ Çõ½ÅÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇコÄɾî ÀÎÇÁ¶ó °³¼± ¹× °¡Ã³ºÐ¼Òµæ Áõ°¡µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñħ½ÀÀûÀ̰í È¿À²ÀûÀÎ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ ½ÃÀåÀÇ ±â¼¼¸¦ ´Ã¸®°í ÀÖÀ¸¸ç, Áß±¹, ÀϺ», Àεµ µîÀÇ ±¹°¡µéÀÌ ÀÌ Áö¿ªÀÇ ÇǺΰú¿ë ¿µ»ó±â±â ½ÃÀåÀÇ ÁÖ¿ä °øÇå±¹À¸·Î ´ëµÎÇϰí ÀÖ½À´Ï´Ù.

º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) °¡Àå ³ôÀº Áö¿ª:

ºÏ¹Ì´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ªÀº ±â¼úÀÇ Áøº¸¿Í ÇǺΠÁúȯÀÇ À¯º´·üÀÇ »ó½Â¿¡ ÀÇÇØ °­·ÂÇÑ ¼ºÀåÀ» ³ªÅ¸³»°í ÀÖ½À´Ï´Ù. ºÏ¹Ì¿¡´Â °í·ÉÈ­ Àα¸°¡ ¸¹½À´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù¿Í °°Àº ½ÅÈï±¹Àº À¯¸®ÇÑ »óȯ Á¤Ã¥°ú È®¸³µÈ ÀÇ·á ÀÎÇÁ¶ó¸¦ º¸À¯Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú °Ç°­ °ü¸® ÀÎÇÁ¶óÀÇ Áøº¸´Â ºÏ¹ÌÀÇ ÇǺΰú ¿µ»ó Àåºñ ½ÃÀåÀÇ ¹ø¿µ¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç°ºÐ¼®
  • ±â¼ú ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ÇǺΰú¿ë ¿µ»ó±â±â ½ÃÀå : Á¦Ç°º°

  • ÇǺΠ°Å¿ï
  • Àû¿Ü¼± ÃÔ»ó ÀåÄ¡
  • ±¤°£¼· ´ÜÃþÃÔ¿µ(OCT) µð¹ÙÀ̽º
  • Çü±¤ À̹Ì¡ ÀåÄ¡
  • ±¤À½Çâ À̹Ì¡ µð¹ÙÀ̽º
  • ÇǺΰú Ä«¸Þ¶ó
  • ÇǺΠǥ¸é ÃøÁ¤ ÀåÄ¡
  • »óó Æò°¡ ÀåÄ¡
  • ±âŸ Á¦Ç°

Á¦6Àå ¼¼°èÀÇ ÇǺΰú¿ë ¿µ»ó±â±â ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ħ½ÀÀû È­»ó ó¸®
  • ºñħ½ÀÀû À̹ÌÁö ó¸®

Á¦7Àå ¼¼°èÀÇ ÇǺΰú¿ë ¿µ»ó±â±â ½ÃÀå : ±â¼úº°

  • ¿ø°Ý ÇǺΰúÇÐ ¼Ö·ç¼Ç
  • ÄÄÇ»ÅÍ Áö¿ø Áø´Ü(CAD) ¼ÒÇÁÆ®¿þ¾î
  • Àü±â ÀÓÇÇ´ø½º ´ÜÃþ ÃÔ¿µ¹ý(EIT)
  • ¶ó¸¸ ºÐ±¤¹ý
  • ±âŸ ±â¼ú

Á¦8Àå ¼¼°èÀÇ ÇǺΰú¿ë ¿µ»ó±â±â ½ÃÀå : ¿ëµµº°

  • ¿©µå¸§ Áø´Ü
  • ÇǺξÏÀÇ Áø´Ü
  • °Ç¼±ÀÇ Áø´Ü
  • ÇǺο° Áø´Ü
  • ¼ÕÅé ÁúȯÀÇ Áø´Ü
  • ¸Ó¸®Ä«¶ô°ú µÎÇÇÀÇ Áúº´ Áø´Ü
  • ¾Ë·¹¸£±â °Ë»ç
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ ÇǺΰú¿ë È­»ó ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø ¹× Ŭ¸®´Ð
  • ÇǺΰú ¼¾ÅÍ
  • È­»ó Áø´Ü¼¾ÅÍ
  • ¿¬±¸±â°ü ¹× Çмú±â°ü
  • ¹Ì¿ë Ŭ¸®´Ð, ¿¡½ºÅׯ½ Ŭ¸®´Ð
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ

Á¦10Àå ¼¼°èÀÇ ÇǺΰú¿ë È­»ó ±â±â ½ÃÀå :Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛ ÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Derma Medical Systems
  • Danaher Corporation
  • Nikon Corporation
  • Canfield Scientific Inc.
  • FotoFinder Systems GmbH
  • Carl Zeiss Meditec AG
  • 3Gen DermLite
  • Metaoptima Technology Inc.
  • Strata Skin Sciences Company
  • Heine Optotechnik GmbH & Co. KG
  • Lucid Inc.
  • ModiQuest Research
  • Michelson Diagnostics Company
BJH 24.04.09

According to Stratistics MRC, the Global Dermatology Imaging Devices Market is accounted for $8.62 billion in 2023 and is expected to reach $12.54 billion by 2030 growing at a CAGR of 14.7% during the forecast period. Dermatology imaging devices play a crucial role in diagnosing and monitoring skin conditions. These devices utilize advanced technologies to provide detailed images of the skin's structure. Dermatologists use these non-invasive tools to examine moles, lesions, and skin abnormalities, aiding in the early detection of skin cancers and other dermatological issues. The high-resolution imaging helps enhance diagnostic accuracy and facilitates more effective treatment planning, contributing to improved patient outcomes in the field of dermatology.

According to the American Cancer Society's 2022 statistics, in the United States, an estimated 99,780 new cases of melanoma of the skin are expected to be reported in 2022. Of those, 57,180 cases are likely to be registered among males and 42,600 in females.

Market Dynamics:

Driver:

Growing incidence of skin disorders

Accurate and effective diagnostic techniques are becoming a growing necessity in dermatology as skin disorders grow more common as a result of aging populations, changes in lifestyle, and pollution. As medical professionals look for cutting-edge technologies for accurate and timely diagnosis of skin conditions, the market for dermatology imaging devices is expanding significantly. Contributing to the market's expansion in response to the rising frequency of skin problems, these devices aid in non-invasive inspection, improving the overall efficiency of dermatological practices.

Restraint:

Limited access to healthcare facilities

In regions with restricted healthcare infrastructure, patients face challenges in obtaining timely dermatological diagnoses and treatments. The disparity in healthcare access also exacerbates the burden of skin diseases, as patients may experience delays in receiving proper dermatological care. This barrier disproportionately affects underserved regions, exacerbating healthcare disparities and impeding the market's potential growth.

Opportunity:

Rising awareness & focus on aesthetic procedures

Technologically improved imaging instruments in dermatology are in greater demand as people place greater emphasis on skin health and attractiveness. These tools are essential for identifying and tracking skin issues, which helps professionals provide accurate and customized cosmetic procedures. With a heightened focus on achieving optimal cosmetic outcomes, the market for dermatology imaging devices is poised for sustained growth, driven by the intersection of medical and aesthetic advancements.

Threat:

High cost of advanced imaging devices

The prohibitive expenses associated with acquiring and maintaining cutting-edge technology limit accessibility for healthcare providers and facilities. This financial barrier hampers widespread adoption, hindering smaller clinics and healthcare institutions from investing in state-of-the-art dermatology imaging equipment. As a result, the unequal distribution of resources may impede the overall growth and accessibility of advanced diagnostic capabilities in dermatology, potentially compromising patient care and diagnostic accuracy.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the market. While there was an initial decline in demand due to disrupted healthcare services and prioritization of covid-related resources, the market rebounded with an increased focus on telemedicine and remote diagnostics. The pandemic underscored the importance of dermatological imaging for virtual consultations, leading to a surge in adoption. However, supply chain disruptions and economic uncertainties continue to pose challenges for market growth in the dermatology imaging devices sector.

The dermatoscopes segment is expected to be the largest during the forecast period

The dermatoscopes segment is estimated to have a lucrative growth. Dermatoscopes are handheld devices used by dermatologists to examine skin lesions and abnormalities. These magnifying instruments provide a close-up view of the skin, enabling professionals to assess moles, pigmented lesions, and other skin conditions with enhanced clarity. With varying designs, including contact and non-contact models, dermatoscopes play a crucial role in dermatological diagnostics, facilitating more accurate and informed decisions about skin health. Their portability and ease of use make them valuable tools in routine skin examinations.

The skin cancer diagnosis segment is expected to have the highest CAGR during the forecast period

The skin cancer diagnosis segment is anticipated to witness the highest CAGR growth during the forecast period. Dermatology imaging devices play a pivotal role in skin cancer diagnosis by offering non-invasive, high-resolution images of the skin. These devices aid dermatologists in accurately assessing skin lesions, distinguishing benign from malignant growths, and determining optimal biopsy locations. The technology enhances early detection, leading to timely intervention and improved prognosis. Additionally, these devices minimize unnecessary biopsies, reducing patient discomfort and healthcare costs.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the growing awareness of skin health and a rising prevalence of dermatological conditions. Key players here namely Minolta and Nidek Corporation are investing in research and development, fostering innovation in imaging solutions. Also, improvements in healthcare infrastructure and rising disposable incomes contribute to the market expansion. Further, the demand for non-invasive and efficient diagnostic tools is fueling the market's momentum, with countries like China, Japan, and India emerging as key contributors to the region's dermatology imaging devices market.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period. The region exhibits robust growth driven by technological advancements and a rising prevalence of skin disorders. North America has the presence of huge aging population. Emerging economies in the region such as United States and Canada has favourable reimbursement policies and a well-established healthcare infrastructure. Moreover, regulatory support and healthcare infrastructure advancements also play pivotal roles in shaping the thriving dermatology imaging devices market in North America.

Key players in the market

Some of the key players profiled in the Dermatology Imaging Devices Market include Derma Medical Systems, Danaher Corporation, Nikon Corporation, Canfield Scientific Inc., FotoFinder Systems GmbH, Carl Zeiss Meditec AG, 3Gen DermLite, Metaoptima Technology Inc., Strata Skin Sciences Company, Heine Optotechnik GmbH & Co. KG, Lucid Inc., ModiQuest Research and Michelson Diagnostics Company.

Key Developments:

In October 2023, Danaher Corporation, has launched the patent-pending CellXpress.ai™ Automated Cell Culture System-an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab.

In April 2023, Nikon Corporation announced the development and launch of the digital imaging microscope "ECLIPSE Ui"*2 as the first-ever microscope for medical use in Japan. The ECLIPSE Ui has a unique design without an eyepiece lens (even though is a microscope), a design which improves the pathologist's observation posture and enables the sharing of observation images on the display.

Products Covered:

  • Dermatoscopes
  • Infrared Imaging Devices
  • Optical Coherence Tomography (OCT) Devices
  • Fluorescence Imaging Devices
  • Photoacoustic Imaging Devices
  • Dermatology Cameras
  • Skin Surface Measurement Devices
  • Wound Assessment Devices
  • Other Products

Modalities Covered:

  • Invasive Imaging
  • Non-invasive Imaging

Technologies Covered:

  • Teledermatology Solutions
  • Computer-Aided Diagnosis (CAD) Software
  • Electrical Impedance Tomography (EIT)
  • Raman Spectroscopy
  • Other Technologies

Applications Covered:

  • Acne Diagnosis
  • Skin Cancer Diagnosis
  • Psoriasis Diagnosis
  • Dermatitis Diagnosis
  • Nail Disorders Diagnosis
  • Hair & Scalp Disorders Diagnosis
  • Allergy Testing
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Dermatology Centers
  • Diagnostic Imaging Centers
  • Research and Academic Institutes
  • Cosmetic & Aesthetic Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dermatology Imaging Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Dermatoscopes
  • 5.3 Infrared Imaging Devices
  • 5.4 Optical Coherence Tomography (OCT) Devices
  • 5.5 Fluorescence Imaging Devices
  • 5.6 Photoacoustic Imaging Devices
  • 5.7 Dermatology Cameras
  • 5.8 Skin Surface Measurement Devices
  • 5.9 Wound Assessment Devices
  • 5.10 Other Products

6 Global Dermatology Imaging Devices Market, By Modality

  • 6.1 Introduction
  • 6.2 Invasive Imaging
  • 6.3 Non-invasive Imaging

7 Global Dermatology Imaging Devices Market, By Technology

  • 7.1 Introduction
  • 7.2 Teledermatology Solutions
  • 7.3 Computer-Aided Diagnosis (CAD) Software
  • 7.4 Electrical Impedance Tomography (EIT)
  • 7.5 Raman Spectroscopy
  • 7.6 Other Technologies

8 Global Dermatology Imaging Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Acne Diagnosis
  • 8.3 Skin Cancer Diagnosis
  • 8.4 Psoriasis Diagnosis
  • 8.5 Dermatitis Diagnosis
  • 8.6 Nail Disorders Diagnosis
  • 8.7 Hair & Scalp Disorders Diagnosis
  • 8.8 Allergy Testing
  • 8.9 Other Applications

9 Global Dermatology Imaging Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Dermatology Centers
  • 9.4 Diagnostic Imaging Centers
  • 9.5 Research and Academic Institutes
  • 9.6 Cosmetic & Aesthetic Clinics
  • 9.7 Other End Users

10 Global Dermatology Imaging Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Derma Medical Systems
  • 12.2 Danaher Corporation
  • 12.3 Nikon Corporation
  • 12.4 Canfield Scientific Inc.
  • 12.5 FotoFinder Systems GmbH
  • 12.6 Carl Zeiss Meditec AG
  • 12.7 3Gen DermLite
  • 12.8 Metaoptima Technology Inc.
  • 12.9 Strata Skin Sciences Company
  • 12.10 Heine Optotechnik GmbH & Co. KG
  • 12.11 Lucid Inc.
  • 12.12 ModiQuest Research
  • 12.13 Michelson Diagnostics Company
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦